Atrial Fibrillation Market (2026–2030): Industry Developments and Trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Atrial Fibrillation Market Progress Between 2026 And 2030?

The atrial fibrillation market size has experienced rapid growth in recent years. Its value is expected to climb from $15.1 billion in 2025 to $17.1 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.2%. The expansion observed historically is attributable to factors such as the increasing prevalence of atrial fibrillation in aging populations, better access to cardiac diagnostic technologies, a wider supply of anticoagulant therapies, the growth of electrophysiology labs, and increasing awareness regarding stroke prevention.

The atrial fibrillation market size is set for significant expansion over the next few years. It is predicted to reach $27.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period stems from factors such as increasing demand for personalized arrhythmia treatment, the rising adoption of wearable cardiac monitoring devices, the expansion of hybrid treatment approaches, growing investments in electrophysiology infrastructure, and an increasing focus on long-term rhythm management outcomes. Key trends anticipated in this period include the increasing adoption of catheter ablation procedures, rising use of advanced cardiac mapping systems, a growing preference for minimally invasive treatments, the expansion of pharmacological rhythm control therapies, and an enhanced focus on early diagnosis and monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Which Factors Are Influencing The Growth Of The Atrial Fibrillation Market?

The escalating incidence of cardiovascular diseases is anticipated to propel the atrial fibrillation market forward. Cardiovascular diseases, a category of conditions impacting the heart and blood vessels such as coronary artery disease, heart failure, and arrhythmias, represent a significant risk to overall cardiovascular health. The growth in cardiovascular conditions highlights a rising need for advanced diagnostic and treatment solutions, thus driving the atrial fibrillation market as healthcare systems and industries respond to the mounting challenges posed by their increasing occurrence. For illustration, in October 2024, the CDC (Centers for Disease Control and Prevention), a U.S-based government agency, reported that 919,032 people died from cardiovascular disease in 2023, which equals 1 in every 3 deaths. Furthermore, about 805,000 people in the United States suffer a heart attack each year. Therefore, the considerable global burden of cardiovascular diseases will stimulate the atrial fibrillation market.

Which Segment Classifications Are Used In The Atrial Fibrillation Market Segment Analysis?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures

Which Trends Are Influencing Demand In The Atrial Fibrillation Market?

Prominent companies in the atrial fibrillation market are introducing advanced products and solutions, including patient-focused clinical decision support tools, to solidify their market presence. Clinical decision support tools (CDST) are software or electronic systems crafted to support healthcare professionals in making well-informed and prompt decisions concerning patient care. These tools are developed to incorporate relevant clinical information from diverse origins. For example, in August 2023, GE HealthCare, a US-based global medical technology enterprise, introduced CardioVisio. This patient-centered clinical decision support tool aims to empower doctors to provide evidence-based clinical guidance, adhering to current atrial fibrillation guidelines, and to visualize longitudinal data from various sources critical for illness advancement. CardioVisio, specifically for atrial fibrillation, can assist cardiologists by streamlining the interpretation of clinical images and furnishing a complete view of the patient’s cardiac history and their healthcare trajectory, which includes prior diagnoses, prescribed medications, interventions, and comorbidities.

Which Firms Are Contributing To The Atrial Fibrillation Market Ecosystem?

Major companies operating in the atrial fibrillation market are AtriCure Inc, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Johnson & Johnson, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Sanofi SA, Bayer AG, Pfizer Inc, Daiichi Sankyo Company Limited, AstraZeneca PLC, Biotronik SE & Co KG, Kardium Inc, Acutus Medical Inc, Apama Medical Inc, CardioFocus Inc, AliveCor Inc, iRhythm Technologies Inc, BioSig Technologies Inc

Get The Full Atrial Fibrillation Market Report:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Which Region Is The Leading Market For The Atrial Fibrillation Market?

North America was the largest region in the atrial fibrillation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Atrial Fibrillation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Browse Through More Reports Similar to the Global Atrial Fibrillation Market 2026, By The Business Research Company

Atrial Septal Defect Market Report 2026

https://www.thebusinessresearchcompany.com/report/atrial-septal-defect-global-market-report

Ventricular Fibrillation Market Report 2026

https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report

Arrhythmia Market Report 2026

https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795